Balyasny Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-42,064
| Closed | -$470K | – | 2010 |
|
|
2023
Q3 | $470K | Buy |
+42,064
| New | +$470K | ﹤0.01% | 1327 |
|
|
2019
Q3 | – | Sell |
-11,013
| Closed | -$929K | – | 1137 |
|
|
2019
Q2 | $929K | Buy |
11,013
+1,210
| +12% | +$102K | 0.01% | 961 |
|
|
2019
Q1 | $936K | Buy |
+9,803
| New | +$936K | 0.01% | 941 |
|
|
2015
Q2 | – | Sell |
-148,610
| Closed | -$4.55M | – | 954 |
|
|
2015
Q1 | $4.55M | Buy |
+148,610
| New | +$4.55M | 0.04% | 357 |
|